Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.06 USD
Change Today -0.04 / -0.66%
Volume 95.8K
ONCS On Other Exchanges
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

oncosec medical inc (ONCS) Key Developments

OncoSec Medical Incorporated - Shareholder/Analyst Call

Annual Shareholder Meeting

OncoSec Medical Inc. Appoints Joann V. Lofgren as Vice President of Market Development

OncoSec Medical Inc. announced the appointment of Joann V. Lofgren to the newly created position of Vice President of Market Development, effective July 6, 2015. In this role, Ms. Lofgren will be responsible for evaluating, designing, and executing on the company's market and product development strategy for all therapeutic products. Most recently Lofgren served as the Marketing Director for Hansen Medical, where she developed and implemented strategic plans to grow the sales of robotic systems and catheters in the $1.5 billion global electrophysiology ablation market.

Oncosec Medical Inc. Announces Executive Changes

OncoSec Medical Inc. announced the appointment of Richard B. Slansky as the company's Chief Financial Officer, with effect from July 6, 2015. Mr. Slansky is responsible for leading financial operations and activities for OncoSec as well as managing financial plans and budgets. Veronica Vallejo, the current Chief Financial Officer of OncoSec, resigned from her position effective June 24, 2015 to pursue other opportunities. Mr. Slansky brings more than 25 years of senior management experience to OncoSec and has a proven track record managing financial investments for life science and technology companies. Prior to joining OncoSec, Mr. Slansky held various financial leadership positions, including: Chief Financial Officer at GenMark Diagnostics Inc.; Chief Financial Officer at Digirad Corporation and President, Chief Financial Officer and Director at SpaceDev Inc.

OncoSec Medical Incorporated(NasdaqCM:ONCS) added to NASDAQ Composite Index

OncoSec Medical Incorporated has been added to Nasdaq Composite Index.

OncoSec Medical Incorporated, Annual General Meeting, Jul 31, 2015

OncoSec Medical Incorporated, Annual General Meeting, Jul 31, 2015., at 09:00 Pacific Standard Time. Location: Lighthouse Room. Agenda: To elect four directors to Board of Directors to serve for a term of one year or until their successors are duly elected and qualified; to ratify the appointment of Mayer Hoffman McCann P.C. as the company's independent registered public accounting firm for the fiscal year ending July 31, 2015; to amend the 2011 Stock Incentive Plan to increase the shares reserved for issuance there under and increase the annual per person limit on stock options, stock appreciation rights, restricted stock and restricted stock units that are intended to qualify for exclusion from the federal tax deduction limitation under Section 162(m) of the Internal Revenue Code; and to transact other business as may properly come before the annual meeting or any adjournment or postponement thereof.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONCS:US $6.06 USD -0.04

ONCS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ONCS.
View Industry Companies

Industry Analysis


Industry Average

Valuation ONCS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOSEC MEDICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at